BlackRock Science and Technology Trust II (BSTZ) is a closed-end fund expertly managed by BlackRock, primarily targeting high-growth opportunities in the science and technology sectors. The fund emphasizes investments in innovative companies pioneering technological advancements and scientific research, positioning itself to leverage the significant growth potential within these evolving fields. With BlackRock's deep industry expertise, BSTZ aims to deliver attractive total returns through a strategic blend of capital appreciation and income. This offering is particularly advantageous for institutional investors seeking portfolio diversification and exposure to enduring trends in technology and healthcare innovation.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 1.08 |
| Price-to-Sales (TTM) | 5.86 |
| EV/Revenue | 5.86 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $68.74M |
| Float | 0 |
| % Insiders | 0.01% |
| % Institutions | 31.16% |
Volatility is currently expanding